In this issue:
Best predictive diagnostic criteria for psoriasis in children
Comparison of psoriasis guidelines for use of apremilast
Targeted therapies for patients with moderate-to-severe psoriasis
Associations between alexithymia and health-literacy
Cyclosporine A for moderate-to- severe plaque psoriasis
Predictive model for screening risk of psoriatic arthritis
Deucravacitinib for moderate-to- severe psoriasis
Childhood tobacco exposure and childhood psoriasis
Quality of life with ixekizumab for paediatric plaque psoriasis
Guselkumab for the treatment of psoriasis
Please login below to download this issue (PDF)